ERBB2 and ovarian cancer: In addition, previous researches have identified the glucose-to-mannose ratio as a risk factor for HER2-positive breast cancer, and its level in serum shows promise as a potential biomarker for ovarian cancer [44], implying its potential as an early diagnostic biomarker.